LHCS academics have recently published a new paper in the journal Molecular Oncology identifying an evolutionary conserved long non-coding RNA that drives the progression of neuroendocrine prostate cancer (the most lethal form of this disease).
In addition, Dr Francesco Crea has also recently contributed to a publication in Cancer Letters reviewing the role of long non-coding RNAs in the resistance cancer cells to the chemotheraputic agent doxorubicin.